The subsidiary, Shenzhen Salubris Medtech Co., Ltd., focuses on the research and development, production, and sales of high-end interventional medical devices. Its product pipeline covers key interventional treatment areas including cardiovascular and cerebrovascular, peripheral vascular, structural heart disease, electrophysiology, and cardiac rhythm management. Adhering to the core value of “patient-centered” and the corporate philosophy of “integrity brings excellence,” the company consistently invests in product development and technological innovation, aiming to create efficient, high-quality innovative medical device products. Through strategic synergy across devices, pharmaceuticals, and services, it is committed to becoming a globally leading platform enterprise in innovative cardiovascular and cerebrovascular devices
